...
首页> 外文期刊>Applied immunohistochemistry and molecular morphology: AIMM >IHC and the WHO Classification of LymphomasCost Effective Immunohistochemistry Using a Deductive Reasoning 'Decision Tree' Approach
【24h】

IHC and the WHO Classification of LymphomasCost Effective Immunohistochemistry Using a Deductive Reasoning 'Decision Tree' Approach

机译:IHC和WHO淋巴瘤分类使用演绎推理“决策树”方法进行成本有效的免疫组化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The 2008 World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues defines current standards of practice for the diagnosis and classification of malignant lymphomas and related entities. More than 50 different types of lymphomas are described, combining fine morphologic criteria with immunohistochemical (IHC), and sometimes molecular, findings. Faced with such a broad range of different lymphomas, some encountered only rarely, and a rapidly growing, ever changing, armamentarium of approximately 80 pertinent IHC "stains", the challenge to the pathologist is to employ IHC in an efficient manner, to arrive at an assured diagnosis as rapidly as possible. This review uses deductive reasoning, after a decision tree or dendrogram model that relies upon recognition of basic morphologic patterns for efficient selection, use and interpretation of IHC markers to classify node-based malignancies by the World Health Organization schema. The review is divided into 2 parts, the first addressing those lymphomas that produce a follicular or nodular pattern of lymph nodal involvement; the second addressing diffuse proliferations in lymph nodes. It is accepted that only specialized centers are able to apply all of the technical resources and experience necessary for definitive diagnosis of unusual cases. Emphasis therefore is given to the more common lymphomas and the more commonly available IHC "stains", for a pragmatic and practical approach that is both broadly feasible and cost effective. By this method an assured diagnosis may be reached in the majority of nodal lymphomas, at the same time developing a sufficiency of data to recognize those rare or atypical cases that require referral to a specialized center.
机译:2008年世界卫生组织《造血组织和淋巴组织肿瘤分类》确定了恶性淋巴瘤和相关实体的诊断和分类的现行实践标准。描述了50多种不同类型的淋巴瘤,将精细的形态学标准与免疫组织化学(IHC)结合在一起,有时还结合了分子发现。面对如此广泛的各种淋巴瘤,其中一些很少见,并且迅速发展,并且不断变化,大约有80种相关的IHC“污点”成为武器库,病理学家面临的挑战是有效地使用IHC来达到尽快确定诊断。在基于决策树或树状图模型的决策树或树状图模型依靠有效地选择,使用和解释IHC标记物以根据世界卫生组织模式对基于结节的恶性肿瘤进行有效选择的决策树或树状图模型之后,本文使用了演绎推理。综述分为两部分,第一部分针对那些产生淋巴结受累的滤泡或结节型淋巴瘤。第二个针对淋巴结中的弥漫性扩散。公认的是,只有专门的中心才能够运用确定的诊断异常情况所需的所有技术资源和经验。因此,将重点放在更常见的淋巴瘤和更常见的IHC“污点”上,以一种务实而实用的方法,这种方法既广泛可行又具有成本效益。通过这种方法,可以在大多数淋巴瘤中获得可靠的诊断,同时开发出足够的数据来识别那些需要转诊至专门中心的罕见或非典型病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号